PRINCETON, N.J. , Nov. 9, 2017 /PRNewswire/ -- Promius Pharma LLC announced today the enrollment of subjects into the phase 3 clinical trials of DFD-03, a tazarotene formulation for the treatment of mild to moderate acne vulgaris. "Promius Pharma's development of novel pipeline assets to ...
Read MoreVantage Consulting Group to host 'OEE Webinar' taking place November 15 HILLSBOROUGH, N.J. , Nov. 9, 2017 /PRNewswire/ -- Vantage Consulting Group , a trusted manufacturing automation expert, today announced it is hosting a webinar on Wednesday, November 15 to highlight opportunities for ...
Read MoreLONDON , November 9, 2017 /PRNewswire/ -- Revenue Forecasts for Deep Brain Stimulation, Spinal Cord, Vagus Nerve, Sacral Nerve and Gastric Electrical Applications (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg ) How this report will benefit you: Read on to ...
Read MoreSubscribe to our Free Newsletters!